Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;21(4):375.
doi: 10.3892/etm.2021.9806. Epub 2021 Feb 19.

A clinical study on the factors associated with nasopharyngeal carcinoma among the Chinese population

Affiliations

A clinical study on the factors associated with nasopharyngeal carcinoma among the Chinese population

Zhenfang Gu et al. Exp Ther Med. 2021 Apr.

Abstract

Nasopharyngeal carcinoma (NC) arises from the nasopharynx epithelium and the majority of NC cases globally are within China and Southeast Asia. Both short palate lung and nasal epithelium clone 1 (SPLUNC1) and myelodysplasia syndrome 1-ectopic viral integration site 1 (MDS1-EVI1) play an important role in carcinogenesis and have been found to be associated with nasopharyngeal carcinoma. In spite of their role in NC, the association between these genes and their polymorphisms in the development of NC has thus far not been studied. In the present study, the relationship between SPLUNC1 (rs2752903, T>C) and MDS1-EVI1 (rs6774494, G>A) polymorphisms and their role in the development of NC among the Chinese population were investigated. From a Chinese population of 1,059 patients with NC and 891 controls, genotype frequencies and the distribution of SPLUNC1 and MDS1-EVI1 polymorphisms were analyzed for possible susceptibility to NC. It was observed that those with MDS1-EVI1 CC (OR, 2.76; 95% CI, 1.96-3.81) and MDS1-EVI1 CT (OR, 1.51; 95% CI, 1.22-2.14) polymorphisms had an increased risk of developing NC. Those with SPLUNC1 AA genotypes also observed a higher risk for NC compared with SPLUNC1 GG genotypes (OR, 2.15; 95% CI, 1.62-3.15). When observing the gene-gene interaction between SPLUNC1 and MDS1-EVI1 polymorphisms, it was found that the presence of both SPLUNC1 CC and MDS1-EVI1 AA alleles was associated with a higher risk for NC compared with those who did not carry both alleles (OR, 6.75; 95% CI, 3.41-12.11). The present study suggested that the association between SPLUNC1 (rs2752903, T>C) and MDS1-EVI1 (rs6774494, G>A) polymorphisms may be a potent risk factor in the occurrence of NC.

Keywords: myelodysplasia syndrome 1-ectopic viral integration site 1; nasopharyngeal carcinoma; polymorphism; short palate lung and nasal epithelium clone 1.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Bar graph representing the association between SPLUNC1 polymorphisms and nasopharyngeal carcinoma for TT (Reference), CT, CC and CT + CC genotypes. TT genotype denotes the reference group. SPLUNC1, short palate lung and nasal epithelium clone 1.
Figure 2
Figure 2
Bar graph representing the association between MDS1-EVI1 polymorphisms and nasopharyngeal carcinoma for GG (Reference), AG, AA and AG + AA genotypes. GG genotype denotes the reference group. MDS1-EVI1, myelodysplasia syndrome 1-ectopic viral integration site 1.

References

    1. Wei WI, Kwong DL. Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol. 2010;3:1–12. doi: 10.3342/ceo.2010.3.1.1. - DOI - PMC - PubMed
    1. Wang Y, Zhang Y, Ma S. Racial differences in nasopharyngeal carcinoma in the United States. Cancer Epidemiol. 2013;37:793–802. doi: 10.1016/j.canep.2013.08.008. - DOI - PMC - PubMed
    1. Lang J, Hu C, Lu T, Pan J, Lin T. Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: Evidence from current practice and future perspectives. Cancer Manag Res. 2019;11:6365–6376. doi: 10.2147/CMAR.S197544. - DOI - PMC - PubMed
    1. Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, Tan IB, Middeldorp JM. Nasopharyngeal carcinoma in Indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012;31:185–196. doi: 10.5732/cjc.011.10328. - DOI - PMC - PubMed
    1. Jain A, Chia WK, Toh HC. Immunotherapy for nasopharyngeal cancer-a review. Chin Clin Oncol. 2016;5(22) doi: 10.21037/cco.2016.03.08. - DOI - PubMed